Truist Financial Corp Precigen, Inc. Transaction History
Truist Financial Corp
- $62.7 Billion
- Q4 2024
A detailed history of Truist Financial Corp transactions in Precigen, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 13,145 shares of PGEN stock, worth $17,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,145Holding current value
$17,745% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding PGEN
# of Institutions
140Shares Held
161MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$113 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$24.2 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$14.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$13.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$11.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $281M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...